Drug Type Gene therapy |
Synonyms ADVM 082, ADVM082 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Color Vision Defects | Preclinical | US | 14 Aug 2024 | |
Color Vision Defects | Preclinical | US | 14 Aug 2024 |